News

May 27, 2017 - Sotera® Wireless To Spotlight Surveillance Monitoring For Patient Safety At AAMI 2016 Read More

May 24, 2017 - CalciMedica Receives Fast-Track Designation For CM4620, A Novel CRAC Channel Inhibitor To Treat Acute Pancreatitis Read More

May 22, 2017 - ViaCyte Receives IND Allowance from FDA and Clearance from Health Canada to Commence International Clinical Trial of PEC-Direct Cell Therapy for High-Risk Type 1 Diabetes Read More

May 22, 2017 - JDRF and ViaCyte Announce Support for Development of PEC-Direct Cell Replacement Therapy for Type 1 Diabetes Read More

May 22, 2017 - ViaCyte Announces $10 Million in Financing Read More

May 10, 2017 - Emerillon Capital and Sanderling Ventures Join Forces Backing a New Precision Medicine Company Based in Montreal, Canada Read More

May 10, 2017 - Emerillon Capital et Sanderling Ventures joignent leurs forces afin de soutenir une nouvelle compagnie montréalaise en médecine de précision Read More

May 2, 2017 - Altor BioScience Corporation Announces FDA Fast Track Designation for Lead Candidate ALT-803 in Patients with Non-Muscle Invasive Bladder Cancer Read More

April 27, 2017 - DalCor Pharmaceuticals to Present at Bloom Burton & Co Healthcare Investor Conference 2017 Read More

April 24, 2017 - ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston Read More